Tectonic Therapeutic Statistics
Total Valuation
TECX has a market cap or net worth of $372.83 million. The enterprise value is $105.63 million.
Important Dates
The last earnings date was Thursday, November 6, 2025, after market close.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TECX has 18.72 million shares outstanding. The number of shares has increased by 239.27% in one year.
| Current Share Class | 18.72M |
| Shares Outstanding | 18.72M |
| Shares Change (YoY) | +239.27% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 40.44% |
| Owned by Institutions (%) | 68.54% |
| Float | 11.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.39 |
| P/TBV Ratio | 1.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 29.15, with a Debt / Equity ratio of 0.00.
| Current Ratio | 29.15 |
| Quick Ratio | 28.64 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,048.10 |
Financial Efficiency
Return on equity (ROE) is -32.21% and return on invested capital (ROIC) is -22.66%.
| Return on Equity (ROE) | -32.21% |
| Return on Assets (ROA) | -21.46% |
| Return on Invested Capital (ROIC) | -22.66% |
| Return on Capital Employed (ROCE) | -28.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.32M |
| Employee Count | 51 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TECX has paid $976,000 in taxes.
| Income Tax | 976,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.15% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -61.15% |
| 50-Day Moving Average | 17.92 |
| 200-Day Moving Average | 20.25 |
| Relative Strength Index (RSI) | 53.38 |
| Average Volume (20 Days) | 363,377 |
Short Selling Information
The latest short interest is 5.00 million, so 26.74% of the outstanding shares have been sold short.
| Short Interest | 5.00M |
| Short Previous Month | 4.82M |
| Short % of Shares Out | 26.74% |
| Short % of Float | 44.90% |
| Short Ratio (days to cover) | 7.77 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -76.51M |
| Pretax Income | -66.32M |
| Net Income | -67.30M |
| EBITDA | -74.96M |
| EBIT | -76.51M |
| Earnings Per Share (EPS) | -$3.88 |
Full Income StatementBalance Sheet
The company has $268.44 million in cash and $1.24 million in debt, giving a net cash position of $267.20 million or $14.28 per share.
| Cash & Cash Equivalents | 268.44M |
| Total Debt | 1.24M |
| Net Cash | 267.20M |
| Net Cash Per Share | $14.28 |
| Equity (Book Value) | 267.53M |
| Book Value Per Share | 14.30 |
| Working Capital | 263.87M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$62.44 million and capital expenditures -$211,000, giving a free cash flow of -$62.65 million.
| Operating Cash Flow | -62.44M |
| Capital Expenditures | -211,000 |
| Free Cash Flow | -62.65M |
| FCF Per Share | -$3.35 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |